Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
F8A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CSGALNACT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRP72 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
YLPM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RHBDF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC1A4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAPRIN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TLX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NAP1L4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GID8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TEAD4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NUP50 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ID4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KAZALD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF84 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UNG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC15A2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on